Contactin-2/TAG1 Antibody (372913) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # FAB17141F

Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # 372913
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human Contactin‑2/TAG1
Leu29-Asn1012
Accession # Q02246
Leu29-Asn1012
Accession # Q02246
Specificity
Detects human Contactin‑2/TAG1 in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) Contactin‑4, rhContactin‑5, recombinant mouse (rm) Contactin‑2, and rmContactin‑3 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for Contactin-2/TAG1 Antibody (372913) [FITC]
Application
Recommended Usage
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Contactin-2/TAG1
Alternate Names
Axonin-1, AXT, CNTN2, Contactin2, TAG1, TAX1
Gene Symbol
CNTN2
Additional Contactin-2/TAG1 Products
Product Documents for Contactin-2/TAG1 Antibody (372913) [FITC]
Product Specific Notices for Contactin-2/TAG1 Antibody (372913) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...